World Health Organization (WHO) estimates from 2017 indicates that 10.5% of medical products available in low- and middle-income countries (LMICs) are “substandard or falsified” (SF). Substandard health products are approved by the national regulators, but they do not comply with adequate standards due to undetected errors, negligence, or poor practice in manufacturing, transportation, or storage. ...
Jean-Christophe Pelissier meets with Minister of Health Minister Hon. Dr. Mohamed Nedhirou Hamed in the light of our collaboration to introduce good pharmaceutical practices in Mauritania. This will be done through: Phase 1: An inventory of private and public wholesalers based on the WHO MQAS and BPDS guidelines Phase 2: A proposal for specifications that ...
29 April 2021 Departmental news Reading time: 2 min (546 words) The World Health Organization, (WHO) has recently published two documents that will be critical for countries’ regulatory system strengthening activities, including regulatory cooperation, convergence and transparency. Good Regulatory Practices (GRP) and Good Reliance Practices (GReP), published as Annexes 10 and 11 in the 55th report of the WHO Expert ...
#TeamEuropeQUAMED was honoured to participate in a high-level round table hosted by Enabel, and in presence of Minister Kitir on May 6. Participants spanning the Belgian life sciences, academic research and development-cooperation ecosystem contemplated potential contributions and added value that Belgium can bring to scaling up the production capacity of vaccines, medicines and medical products ...
QUAMED consultant Jean-Christophe Pelissier in Guinea with the team from the Central Pharmacy of Guinea for the evaluation of the PERFAPPRO program. As a reminder, the PERF-APPRO project was officially launched on July 17, 2017, in Ouagadougou. It aims to “contribute to ensuring the quality of essential health products supplied by CAME’s member National Purchasing ...
Our consultant Chiel Lijdsman (first on the left) working with the team of the CAMME in Djibouti (QA pharmacist Meina Abdillah third from right) on the PERFAPPRO evaluation. This evaluation was commissioned by ACAME and executed by QUAMED. The evaluation is taking place in Comoros, Djibouti, Mauritania, Guinea and Niger
Our consultant Chiel Lijdsman and Pharmacist Malika Djamadar working at Ocopharm in Comoros for an ACAME commissioned an evaluation of the PERFAPPRO program. Looking at MQAS standards. Pharmacist and consultant Jean Christophe Pelissier working with Dr Brahim Ould Saleh, Quality Assurance Manager of the CAMEC in Mauritanie working on the PERFAPPRO evaluation for ACAME.
Be-cause Health & QUAMED literature updates Ref. Twesigye G, Hafner T, Guzman J. Making the investment case for national regulatory authorities. J Pharm Pol Practices 2021: 14-16; https://doi.org/10.1186/s40545-021-00299-7 Dear Friend, In the attached paper, Twesigye and colleagues make an important case that there is a need to support the strengthening of national regulatory authorities (NRAs), which play an ...
QUAMED is pleased to have signed the WHO declaration for the equitable rollout of COVID19Vaccines. We believe it is a moral imperative and the most effective way to protect communities from falsified and diverted vaccines. The link for more information https://www.who.int/campaigns/annual-theme/year-of-health-and-care-workers-2021/vaccine-equity-declaration.
We are delighted that the RCE-VIHSCM (https://hscm.ur.ac.rw/), part of the University of Rwanda, has positively evaluated our proposal to develop for them a Master’s Degree Program in Pharmaceutical Quality Assurance and Quality Control. The proposal was developed by a consortium composed of QUAMED, ITM, Action Medeor and two other organisations. We hope to finalize the ...
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.